Dr. Makower is the Founder & Chief Executive Officer of ExploraMed II, Inc.,
a medical device incubator based on the west coast and is also a Venture Partner
with New Enterprise Associates.
Dr. Makower serves as a Consulting Associate Professor of Medicine at Stanford
University Medical School and is Director of Stanford’s Biodesign Innovation
Program.
Prior to this, he was Founder, Chairman and Chief Technical Officer of TransVasc...
more
Dr. Makower is the Founder & Chief Executive Officer of ExploraMed II, Inc.,
a medical device incubator based on the west coast and is also a Venture Partner
with New Enterprise Associates.
Dr. Makower serves as a Consulting Associate Professor of Medicine at Stanford
University Medical School and is Director of Stanford’s Biodesign Innovation
Program.
Prior to this, he was Founder, Chairman and Chief Technical Officer of TransVascular,
Inc. a company focused on the development of a completely catheter-based coronary
bypass technology, which was acquired by Medtronic, Inc. in 2003, and Founder
and Chairman of EndoMatrix, Inc., a company focused on the development of a novel
therapy for incontinence and GI Reflux, which was acquired by C.R. Bard in 1997.
Up until 1995, Dr. Makower was Founder and Manager of Pfizer’s Strategic
Innovation Group, a group chartered to create new medical device technologies
and businesses for Pfizer’s medical devices businesses.
Dr. Makower holds over four dozen patents for various medical devices in the
fields of Cardiology, General Surgery, Drug Delivery and Urology. Dr. Makower
holds a Masters of Business Administration degree from Columbia University, a
Doctor of Medicine degree from the New York University School of Medicine, and
a Bachelor of Science degree in Mechanical Engineering from the Massachusetts
Institute of Technology.
Dr. Makower also serves as Chairman of the Board for Acclarent, Inc. - a venture
backed company focused on the treatment of ENT disorders, and NeoTract, Inc. – ExploraMed’s
most recent spin out, and on the Board of Directors for Intrinsic Therapeutics,
Inc. - a venture backed private company developing innovative spinal therapies,
and ReVance, Inc. – a venture backed private company developing new molecular
carriers to transport therapeutic substances across membranes
less
